Clinical Study
A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients
Table 2
Measurement of median (min; max) HCV viral load at month 12 in patients completing the study*.
| ||||||||||||||||||||||||||||||||||||||||
PAS: Primary analysis set: All randomized and transplanted subjects with baseline viral load above the limit of quantification. FAS: Full analysis set: All randomized and transplanted patients *Patients completing the study with data available within ± 14 days of day 365. † Wilcoxon rank sum test for superiority of TAC/DAC over TAC/STR. |